FreeStyle Libre system is now available for reimbursement in the United Kingdom.- Abbott

Abbott has announced that the FreeStyle Libre system is now available for reimbursement in the United Kingdom . The National Health Service (NHS) Business Services Authority has approved the listing on the Drug Tariff for the FreeStyle Libre system for people with diabetes using insulin. This means that from 1 November 2017 it will be available for reimbursement via the NHS across England and Wales , NHS Scotland, and the Health and Social Care in Northern Ireland.

Abbott's FreeStyle Libre system is designed to change how people with diabetes measure their glucose levels and ultimately help them achieve better health outcomes. The system automatically reads glucose levels through a sensor, approximately the size of a U.S. quarter, that is worn on the back of the upper arm for up to 14 days, eliminating the need for calibration and routine finger sticks. Two published clinical trials including one published in The Lancet, together with real-world evidence from more than 50,000 users show that people with diabetes who use the FreeStyle Libre system scan their glucose levels an average of 15 times per day. The studies show that people who scan more frequently spend less time in hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar) and demonstrate improved glucose control .